AbbVie and Momenta announce Humira patent licence agreement
08-11-2018
AbbVie and Amgen settle Humira clash
29-09-2017
09-04-2018
miodrag ignjatovic / iStockphoto.com
AbbVie has secured another settlement relating to litigation over Humira (adalimumab), a drug used to treat multiple types of arthritis as well as psoriasis.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
AbbVie, Samsung Bioepis, Humira, patent infringement, settlement, litigation, biosimilar